Firstly, as of today (2019-07-15) we’ve determined the following resources to be extremely useful for TCR2 Therapeutics Inc. investors – we recommend taking a look. Take your time with the following:
Beat The Market Analyzer: https://logistics-business-review.com/recommended-tool-for-TCRR-investors (this is a fantastic tool – use this to analyze TCR2 Therapeutics Inc. in much more depth)
MM Publishing: https://logistics-business-review.com/mmpublishing-for-TCRR-investors
Trading Code: https://logistics-business-review.com/tradingcode-for-TCRR-investors
Trader HR: https://logistics-business-review.com/traderHR-for-TCRR-investors
REPORTING FOR 2019-07-15 | LOGISTICS-BUSINESS-REVIEW.COM: We have conducted a deep analysis of how TCR2 Therapeutics Inc. ($TCRR) has been trading over the last 2 weeks and the past day especially. On its latest session, TCR2 Therapeutics Inc. ($TCRR) opened at 13.8, reaching a high of 13.8507 and a low of 12.855 before closing at a price of 13.0. There was a total volume of 31520.
VOLUME INDICATORS: We saw an accumulation-distribution index of 538.7442, an on-balance volume of 13.19, chaikin money flow of 38.27811 and a force index of -0.0527. There was an ease of movement rating of 0.00676, a volume-price trend of -2.28982 and a negative volume index of 1000.0.
VOLATILITY: We noted an average true range of 0.89708, bolinger bands of 13.27996, an upper bollinger band of 12.65204, lower bollinger band of 12.855, a bollinger high band indicator of 1.0, bollinger low band indicator of nan, a central keltner channel of 13.5019, high band keltner channel of 13.4512, low band keltner channel of 13.5526, a high band keltner channel indicator of 1.0 and a low band keltner channel indicator of 1.0. There was a donchian channel high band of 12.855, a donchian channel low band of 12.855, a donchian channel high band indicator of 1.0, and a donchian channel low band indicator of 1.0.
TREND: We calculated a Moving Average Convergence Divergence (MACD) of 0.00498, a MACD signal of 0.00277, a MACD difference of 0.00221, a fast Exponential Moving Average (EMA) indicator of 12.855, a slow Exponential Moving Average (EMA) indicator of 12.855, an Average Directional Movement Index (ADX) of unknown, an ADX positive of 20.0, an ADX negative of 20.0, a positive Vortex Indicator (VI) of 1.0, a negative VI of 1.0, a trend vortex difference of 0.11953, a trix of -13.31106, a Mass Index (MI) of 1.0, a Commodity Channel Index (CCI) of -66.66667, a Detrended Price Oscillator (DPO) of 2.77418, a KST Oscillator (KST) of -177.50025 and a KST Oscillator (KST Signal) of -177.50025 (leaving a KST difference of 3.55105). We also found an Ichimoku rating of 13.82535, an Ichimoku B rating of 13.82535, a Ichimoku visual trend A of 16.73143, an Ichimoku visual trend B of 16.33144, an Aroon Indicator (AI) up of 4.0 and an AI indicator down of 4.0. That left a difference of 4.0.
MOMENTUM: We found a Relative Strength Index (RSI) of 50.0, a Money Flow Index (MFI) of 49.99673, a True Strength Index (TSI) of -100.0, an ultimate oscillator of -55.98588, a stochastic oscillator of 1963.90533, a stochastic oscillator signal of 1963.90533, a Williams %R rating of 1863.90533 and an awesome oscillator of -0.00614.
RETURNS: There was a daily return of -17.75002, a daily log return of 1.71221 and a cumulative return of 1.72695.
What the heck does all of this mean? If you are new to technical analysis, the above may be gibberish to you, and that’s OK (though we do advise learning these things). The bottom line is that AS OF 2019-07-15 (if you are reading this later, the analysis will be out of date), here is what our deep analysis of technical indicators are telling us for TCR2 Therapeutics Inc. ($TCRR)…
For a more complete analysis, run all of this through the BTMA software. Also, to stay up to date with what is happening on TCR2 Therapeutics Inc., we strongly advise TCR2 Therapeutics Inc. investors to subscribe to MarketBeat.com’s daily email newsletter for updates, news and analyst ratings on stocks like TCR2 Therapeutics Inc. – without this you are trading blind:
We will of course continue to cover the news and price action of TCR2 Therapeutics Inc., but it’s easiest for you to just subscribe to MarketBeat’s newsletter above so you don’t miss anything.
DISCLAIMER: We are not registered investment advisers and the above analysis should be taken at face value only. We strongly advise against buying or selling TCR2 Therapeutics Inc. ($TCRR) based solely on our analysis above, and are not responsible for any losses that you may incur if you choose make any investment decisions based on the above.